Middle-East & Africa Preventive Vaccine Market By Vaccine Type (Live, Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines And Recombinant Vector Vaccines), By End User (Paediatric And Adult Vaccines) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

Middle-East & Africa Preventive Vaccine Market By Vaccine Type (Live, Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, Subunit Vaccines, Conjugate Vaccines, DNA Vaccines And Recombinant Vector Vaccines), By End User (Paediatric And Adult Vaccines) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2016–2021)

ID: 145 | Pages: 130 | December 2016 | Region: Middle East and Africa


The Middle-East & Africa Preventive Vaccine market is valued at $2.42 Billion in 2015 and is predicted to reach $ 4.28 billion by 2020 at an annual growth rate of 12.07 %. Recently there has been a substantial growth in the vaccine market with the rising incidences of cancer & HIV cases. World Health Organization growth estimations indicate the market may increase in value to almost 54.5 billion 2020, with the arrival of new therapeutic preventive, and adult vaccines.

The vaccine Market is different from other product markets. Although it is relatively small compared to the pharmaceutical market, it has a tremendous growing opportunities and is growing at a faster rate. Major players of the market have already been investing heavily in the vaccine market and as many as 120 new vaccines are in the pipeline of these companies.

The higher growth rate of the market is attributed to the drivers like, increase funding from the government for vaccine development, huge investments by the multinational companies in the R&D department of the preventive vaccines, technological advancements making it easier for new innovations, initiatives by NGO’s. However, there are few restrains that the market has to overcome like high capital expenditures, stringent policies by the government, high cost of treatment.

The Middle-East & Africa Preventive Vaccines Market is segmented based on vaccine as Live, attenuated vaccines, Subunit vaccines, Inactivated vaccines, Toxoid vaccines, DNA, vaccines Conjugate vaccines and Recombinant vector vaccines. And also, based on age groups the market is categorized as Paediatric Vaccine (Pneumococcal, MMR, Varicella, Hepatitis, Poliovirus, HIB and others) and Adult vaccines (Influenza, Cervical Cancer, Hepatitis, Zoster and others). In addition, the market in Middle-East & Africa Market is analysed under major regions namely, Middle-East and Africa.

Historically many of the multinational vaccine companies have been investing huge sums in research and development resulting in new innovations in the market. The major players in the preventive vaccine market are GlaxoSmithKline, plc, Merck and Company, Bavarian Nordic, CSL Limited, Emergent BioSolutions Inc., Novartis AG, Johnson and Johnson, MedImmune, LLC, Pfizer, Inc., and Sanofi Pasteur.

 

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Analysis Design                         

                2.3 Research Phases                      

                                2.3.1 Secondary Research            

                                2.3.2 Primary Research 

                                2.3.3 Econometric Modelling     

                                2.3.4 Expert Validation  

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 New Developments                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 By Vaccine Type                       

                                5.1.1 Live, Attenuated Vaccines

                                5.1.2 Inactivted Vaccines             

                                5.1.3 Toxoid Vaccines    

                                5.1.4 Subunit vaccines  

                                5.1.5 Conjugate vaccines             

                                5.1.6 DNA vaccines         

                                5.1.7 Recombinant vector vaccines          

                5.2 By End User               

                                5.2.1 Paediatric Vaccine

                                                5.2.1.1 Pneumococcal

                                                5.2.1.2 MMR

                                                5.2.1.3 Varicella

                                                5.2.1.4 Hepatitis

                                                5.2.1.5 Poliovirus

                                                5.2.1.6 HIB

                                                5.2.1.7 Others

                                5.2.2 Adult Vaccines      

                                                5.2.2.1 Influenza

                                                5.2.2.2 Cervical Cancer

                                                5.2.2.3 Hepatitis

                                                5.2.2.4 Zoster

                                                5.2.2.5 Others

6. Geographical Analysis                                              

                6.1 Introduction                              

                6.2 Middle-East               

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 GlaxoSmithKline, plc.                             

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Strategic Evaluation and Operations            

                                8.1.4 Financial analysis  

                                8.1.5 Legal issues            

                                8.1.6 Recent Developments       

                                8.1.7 SWOT analysis       

                                8.1.8 Analyst View          

                8.2 Merck and Company                              

                8.3 Bavarian Nordic                        

                8.4 CSL Limited                 

                8.5 Emergent BioSolutions Inc.                  

                8.6 Novartis AG                

                8.7 Johnson and Johnson                             

                8.8 MedImmune, LLC                    

                8.9 Pfizer, Inc.                   

                8.10 Sanofi Pasteur                        

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Expert Opinions                                         

                10.1 Market Outlook                     

                10.2 Investment Opportunities                 

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. Middle East & Africa Preventive Vaccines Market By Region, From 2015-2020 ( USD Billion )
  2. Middle East & Africa Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  3. Middle East & Africa Live, Attenuated Vaccines Market By Region, From 2015-2020 ( USD Billion )
  4. Middle East & Africa Inactivated Vaccines Market By Region, From 2015-2020 ( USD Billion )
  5. Middle East & Africa Toxoid Vaccines Market By Region, From 2015-2020 ( USD Billion )
  6. Middle East & Africa Subunit vaccines Market By Region, From 2015-2020 ( USD Billion )
  7. Middle East & Africa Conjugate vaccines Market By Region, From 2015-2020 ( USD Billion )
  8. Middle East & Africa DNA vaccines Market By Region, From 2015-2020 ( USD Billion )
  9. Middle East & Africa Recombinant vector vaccines Market By Region, From 2015-2020 ( USD Billion )
  10. Middle East & Africa Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  11. Middle East & Africa Paediatric Vaccines Market By Region, From 2015-2020 ( USD Billion )
  12. Middle East & Africa Adult Vaccines Market By Region, From 2015-2020 ( USD Billion )
  13. Middle East & Africa Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  14. Middle East & Africa Pneumococcal Vaccines Market By Region, From 2015-2020 ( USD Billion )
  15. Middle East & Africa MMR Vaccines Market By Region, From 2015-2020 ( USD Billion )
  16. Middle East & Africa Varicella Vaccines Market By Region, From 2015-2020 ( USD Billion )
  17. Middle East & Africa Hepatitis Vaccines Market By Region, From 2015-2020 ( USD Billion )
  18. Middle East & Africa Poliovirus Vaccines Market By Region, From 2015-2020 ( USD Billion )
  19. Middle East & Africa HIB Vaccines Market By Region, From 2015-2020 ( USD Billion )
  20. Middle East & Africa Other Paediatric Vaccines Market By Region, From 2015-2020 ( USD Billion )
  21. Middle East & Africa Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  22. Middle East & Africa Influenza Vaccines Market By Region, From 2015-2020 ( USD Billion )
  23. Middle East & Africa Cervical Cancer Vaccines Market By Region, From 2015-2020 ( USD Billion )
  24. Middle East & Africa Hepatitis Vaccines Market By Region, From 2015-2020 ( USD Billion )
  25. Middle East & Africa Zoster Vaccines Market By Region, From 2015-2020 ( USD Billion )
  26. Middle East & Africa Other Adult Vaccines Market By Region, From 2015-2020 ( USD Billion )
  27. Middle East Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  28. Middle East Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  29. Africa Preventive Vaccines Market By Vaccine Type, From 2015-2020 ( USD Billion )
  30. Africa Preventive Vaccines Market By End User, From 2015-2020 ( USD Billion )
  31. Middle East Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  32. Africa Paediatric Vaccines Market By Type, From 2015-2020 ( USD Billion )
  33. Middle East Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
  34. Africa Adult Vaccines Market By Type, From 2015-2020 ( USD Billion )
Middle East And Africa Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, G...
Latin America Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Tr...
Asia Pacific Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Tre...
Europe Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, A...
North America Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Tr...
Metaxalone Market By Indication (Bone Pain, Muscle Pain, Tunnel Syndromes, Joint Pain And Others), By End User (Hospitals, Clinics And Others) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Fore...
Middle East And Africa Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extre...
Latin America Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepi...
Asia Pacific Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepin...
Europe Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepiness, C...
North America Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepi...
Narcolepsy Drugs Market By Type (Central Nervous System Stimulants, Tricyclic Antidepressants, Sodium Oxybate, Selective Serotonin Reuptake Inhibitor, And Others), By Indication (Daytime Extreme Sleepiness, Cataplex...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2018 Market Data Forecast
All Rights Reserved.